morning-trading

U.S. Fed awards $23.24 billion in reverse repos

The Federal Reserve on Monday awarded $23.24 billion of one-day, fixed-rate reverse repurchase agreements to 17 bidders at an interest rate of 0.25 percent, the New York Fed said on its website. The reverse repurchase agreement

See the rest here: 
U.S. Fed awards $23.24 billion in reverse repos

morning-trading

Exclusive: Medivation succumbs to pressure to explore sale -sources

U.S. cancer drug maker Medivation Inc has decided to explore a sale following a $9.3 billion acquisition offer from France's Sanofi SA and interest from other companies, people familiar with the matter said on Monday. Pfizer Inc and Amgen Inc are among the companies that have signed non-disclosure agreements with Medivation, which allow them to obtain confidential information about the company, the people said. Sanofi made its

Go here to read the rest:
Exclusive: Medivation succumbs to pressure to explore sale -sources

morning-trading

Tribune Publishing adopts poison pill to stop Gannett bid

(Reuters) – Newspaper publisher Tribune Publishing Co said its board had adopted a shareholder rights plan – popularly known as a “poison pill” – in a bid to thwart Gannett Co Inc's unsolicited takeover offer. Tribune shares fell nearly 6 percent in morning trading on Monday, while Gannett shares were little

See the rest here:
Tribune Publishing adopts poison pill to stop Gannett bid